Business Wire

The Quad Investors Network Launches with Advisory Board, Expert Groups

20.5.2023 17:43:00 EEST | Business Wire | Press release

Share

The Quad Investors Network formally launched today in parallel with the Quad Leaders meeting in Hiroshima, Japan. The Network is an independent forum of public, private, and philanthropic stakeholders from the four Quad nations, created to foster cooperation, collaboration, and co-investment into critical technologies and supply chain resilience to develop innovative solutions to the greatest economic and security challenges in the Indo-Pacific region. Membership in the network is by invitation only.

Governments participating in the security dialogue, a strategic endeavor between Australia, India, Japan, and the United States, also jointly welcomed the formation of the board and the network’s continued efforts to expand capital and partnership opportunities in critical and emerging technologies across the Quad.

“Critical and emerging technologies will profoundly shape our future. By seeking to accelerate the development and manufacturing of these technologies, from semiconductors to quantum to clean energy, the Quad Investors Network demonstrates the tremendous potential of the Quad nations to mobilize world-class talent and investment to foster a more prosperous, resilient, and innovative Indo-Pacific,” said Jake Sullivan, U.S. National Security Advisor.

As part of the launch, the Quad Investors Network announced the formation of an Advisory Board, composed of world-class business, investment, and thought leaders from the four Quad nations. The Advisory Board includes former Telstra CEO Andy Penn AO; former Australian Ambassador to the United States Arthur Sinodinos AO; Founder and CEO of Breyer Capital Jim Breyer; former Bell Labs President Jeong Kim; Chairman Emeritus of JSR Corporation Koshiba Mitsunobu; and Japan Business Federation Managing Director Hara Ichiro.

“The Quad Investors Network serves as an important, exciting forum for executives, investors, and technologists to collaborate and generate greater co-investment in critical and emerging technologies. These technologies will only grow in importance in the future, and I am honored to be a member of the network’s Advisory Board,” said former Telstra CEO Andy Penn.

The Quad Investors Network also established five expert working groups focused on artificial intelligence, semiconductors, clean energy and critical minerals, mobile networks, and quantum information sciences.

Entrepreneur and investor Karl Mehta will serve as the inaugural Chairman of the Quad Investors Network. Mehta is a serial entrepreneur, author, investor, engineer, and civil servant with more than 30 years of experience in founding, building, and funding technology companies in the U.S. and international markets.

“I am honored to lead, and be a part, of such an august group of individuals and organizations which have come together to work on some of the most pressing critical technology issues facing the Quad,” said Mehta. “I look forward to making further progress and contributing to the economic and national security of the four Quad nations through our efforts.”

Full List of the Quad Investors Network Advisory Board:

  • Thomas Bell, CEO of Leidos
  • Jim Breyer, Founder and CEO of Breyer Capital
  • Kris Gopalakrishnan, Chairman of Axilor Ventures
  • Hara Ichiro, Managing Director of Japan Business Federation
  • Hon. Joe Hockey, Founding Partner and President of Bondi Partners
  • Ashok Jacob, Executive Chairman and Portfolio Manager for Ellerston Capital
  • Lydia Jett, Managing Partner at Softbank Investment Advisers
  • Jeong Kim, Chairman of Kiswe Mobile Inc.
  • Koshiba Mitsunobu, Chairman Emeritus of JSR Corporation
  • Arun Kumar, Managing Partner of Celesta Capital
  • Paul Kwan, General Partner at General Catalyst
  • Nakahama Fumitaka, Managing Corporate Executive and Group Head of Global Corporate and Investment Banking Business at MUFG
  • Jeff Nuechterlein, Managing Partner of Nue Capital LLC
  • Andy Penn AO, Former CEO of Telstra
  • Bec Shrimpton, Defence Strategy and National Security Director at the Australian Strategic Policy Institute
  • Hon. Arthur Sinodinos AO, Former Australian Ambassador to the United States
  • Hon. Sugiyama Shinsuke, Former Japanese Ambassador to the United States
  • Yanase Tadao, Senior Executive Vice President at Nippon Telegraph and Telephone Corporation
  • Ankur Verma, Senior Vice President at Tata Sons

About The Quad Investors Network: The Quad Investors Network (“The Network”) was formed to develop innovative solutions to the greatest economic and security challenges facing the Quad nations in the Indo-Pacific region through joint research, co-investments, and strategic partnerships. The network will be an independent, membership forum composed of leading industry, government, capital market, and academic organizations from the Quad nations.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Alex El-Fakir
201-328-2930
info@quadinvestorsnetwork.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye